Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway
Background. Myocardial ischemia/reperfusion (I/R) injury is a severe heart problem resulting from restoring coronary blood flow to the myocardium after ischemia. This study is aimed at ascertaining the therapeutic efficiency and action mechanism of bardoxolone methyl (BARD) in myocardial I/R injury....
Saved in:
Main Authors: | Anwu Huang (Author), Zhaolin Wang (Author), Hua Tang (Author), Zhuyin Jia (Author), Xiaojun Ji (Author), Xuehua Yang (Author), Wenbing Jiang (Author) |
---|---|
Format: | Book |
Published: |
Hindawi-Wiley,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Isoliquiritigenin Ameliorates Ischemia-Induced Myocardial Injury via Modulating the Nrf2/HO-1 Pathway in Mice
by: Yao D, et al.
Published: (2022) -
Methane saline suppresses ferroptosis via the Nrf2/HO-1 signaling pathway to ameliorate intestinal ischemia-reperfusion injury
by: Qingrui Fan, et al.
Published: (2024) -
The Effects of Two Nrf2 Activators, Bardoxolone Methyl and Omaveloxolone, on Retinal Ganglion Cell Survival during Ischemic Optic Neuropathy
by: Jia-Ying Chien, et al.
Published: (2021) -
Sappanone A Protects Against Myocardial Ischemia Reperfusion Injury by Modulation of Nrf2
by: Shi X, et al.
Published: (2020) -
The Nrf2/HO-1 Pathway Mediates the Antagonist Effect of L-Arginine On Renal Ischemia/Reperfusion Injury in Rats
by: Fei Tong, et al.
Published: (2017)